Gene Query: NLE1

Dataset Description Geneva Score
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 32.34
Dtx3L and Androgen Signaling in Prostate Cancer 30.46
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 26.58
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 21.36
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 20.98
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 20.98
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 19.44
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 18.47
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 17.64
Survival of pancreatic cancer cells lacking KRAS function 17.61
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 16.31
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 15.8
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 15.42
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 14.94
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 14.5
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 14.3
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 14.02
Control of prostate tumour growth by the long non-coding RNA GHSROS 13.36
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 13.26
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 13.17
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 12.91
Hijacking of stress response machinery by oncogenes in acute leukaemia 12.91
The landscape of alternative splicing in aggressive prostate cancers 12.89
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 12.27
EWSR1 influences alternative splicing through direct and indirect mechanisms 12.27
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 11.87
snRNAs as regulators of alternative splicing 11.5
Genome wide expression change by RNF168 knocking down in NEC cells 11.35
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 11.3
RNAseq Analysis in glioblastoma cells treated with Mepazine 11.29
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 11.22
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 11.2
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 11.08
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 10.98
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.93
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 10.93
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 10.87
U1 snRNP telescripting regulates size-function stratified human genome 10.49
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 10.36
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 10.16
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 10.11
Gene expression analysis of the impact of TDP-43 knockout in human cells. 10.07
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.01
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 9.79
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.55
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 9.54
The Human Testis Cell Atlas via Single-cell RNA-seq 9.39
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 9.32
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 9.3
Cajal bodies are linked to genome conformation [RNA-Seq] 9.24
Cajal bodies are linked to genome conformation 9.24
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 9.18
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 9.09
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 9.09
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 9.08
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 8.99
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 8.99
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.98
Glioblastoma stem cells infected by ZIKA virus 8.88
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 8.87
Illumina Total RNA-seq in HeLa 8.67
A map of gene expression in neutrophil-like cell lines 8.56
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.5
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 8.39
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 8.23
Gene expression profiling of leukemia cells following asparagine depletion 8.2
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 8.19
Effect of FGF13 depletion on the H460 cell line 8.16
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 8.15
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 8.15
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.14
Paxillin regulates genomic networks in prostate cancer [LNCaP] 8.08
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.06
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.06
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 8.05
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 8.01
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 7.99
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 7.95
Global analysis of alternative splicing regulated by RBM10 7.84
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.83
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 7.82
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 7.76
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 7.75
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 7.73
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 7.71
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 7.71
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.65
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.55
N6-methyladenine DNA Modification in Glioblastoma 7.55
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 7.53
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 7.37
Regulating Interleukin-2 activity with engineered receptor signaling clamps 7.3
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 7.25
RNA seq with AML (NB4) cells upon FTO inhibition 7.21
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.13
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.13
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 7.12
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 7.06
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.03
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 7.01
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.99
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.93
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.93
Transcriptome analysis upon C6orf203 silencing 6.89
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 6.85
Differential Protein Occupancy Profiling of the mRNA Transcriptome 6.82
RNA-seq analysis of AML cells in response to ASLAN003 6.78
The cohesin complex prevents Myc-induced replication stress 6.76
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.74
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.74
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 6.73
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 6.67
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 6.65
IDH3a KO RNA-seq 6.64
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 6.59
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 6.59
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 6.53
R430: A potent inbibitor of DNA and RNA viruses 6.44
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 6.42
RNA sequencing of human mammary epithelial cells 6.42
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 6.4
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 6.34
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 6.34
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 6.34
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 6.34
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 6.33
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 6.31
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 6.31
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.3
Differential gene expression of human melanoma cells [RNA-seq] 6.3
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 6.29
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 6.25
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 6.25
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 6.24
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.23
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 6.21
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 6.21
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 6.21
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 6.16
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 6.16
Effect of drugs on transcriptomic profiles 6.11
Patient-derived luminal breast cancer xenografts with progestins 6.05
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 6.05
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 6.0
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 6.0
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 6.0
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.98
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.95
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 5.93
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 5.86
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 5.86
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 5.84
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 5.81
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 5.81
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 5.8
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.74
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 5.7
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.7
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.7
PRDM1 inhibits proliferation of human colon cancer organoids 5.62
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.57
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 5.56
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.52
Identification of global regulators of T-helper cell lineage specification 5.52
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 5.5
Peptidomimetic blockade of MYB in acute myeloid leukemia 5.5
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.48
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 5.48
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.44
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.38
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 5.37
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 5.34
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 5.34
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 5.3
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 5.28
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 5.27
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 5.27
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 5.25
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 5.25
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 5.24
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 5.24
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 5.23
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 5.23
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 5.21
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 5.18
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 5.18
RNA-seq of YB5 cells treated with Proscillaridin A 5.15
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 5.14
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 5.14
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.08
Gene expression profile in breast cancer cells 5.08
RNA seq comparison between scrambled and shGRP78 cells 5.08
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 5.04
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.04
Global gene expression profile of dasatinib-resistant RCH-ACV cells 5.03
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 5.02
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 5.02
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 4.98
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.98
Real-time observation of light-controlled transcription in living cells 4.93
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 4.88
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 4.88
Identification of Sin3B regulated genes during quiescence 4.86
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.86
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.84
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 4.81
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.81
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.81
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.81
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 4.8
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 4.79
RNA-seq analysis of BAP1-depleted uveal melanoma cells 4.78
LNCaP treated with iBET 4.76
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 4.73
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 4.72
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.72
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 4.72
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.7
A549 cells and MSR-A549 cells 4.69
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 4.69
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 4.64
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 4.63
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.63
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 4.63
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.61
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.61
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 4.61
High-throughput sequencing of pluripotent cells 4.6
p53 activity results in DNA replication fork processivity 4.59
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.59
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.55
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 4.55
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 4.54
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.51
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.51
RNA-seq analysis of control and Myc-induced U2OS cells 4.5
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 4.48
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.45
The role of the Calcium-Sensing receptor in colorectal cancer 4.44
MYC dependent mRNA translation shapes gene expression and cell biology 4.4
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 4.38
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 4.38
Functional role of SLIT2 and ROBO1 in trophoblasts 4.35
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.34
G-quadruplex structures mark human regulatory chromatin 4.31
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 4.29
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.29
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.27
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 4.24
Seletive inhibition of CDK9 in DLBCL cell lines 4.24
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.23
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.23
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.22
LncRNA-GAS5 negative regulation of YAP-target genes expression 4.22
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 4.22
Hepatitis C virus functionally sequesters miR-122 4.2
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.2
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.2
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.2
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.18
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 4.17
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.17
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 4.13
High-efficiency RNA-based reprogramming of human primary fibroblasts 4.1
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.09
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.07
miR941 overexpression experiment 4.06
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.06
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 4.05
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.05
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.05
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.05
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 4.04
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 4.04
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 4.03
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 3.99
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 3.99
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.98
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 3.97
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 3.97
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.92
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 3.91
Controlling for gene expression changes in transcription factor protein networks. 3.89
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.86
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.86
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.85
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.83
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 3.83
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 3.79
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 3.78
RNA splicing alteration on glioblastoma and normal neural stem cells 3.75
Genome-wide chromatin analysis of Ewing sarcoma 3.74
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 3.74
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 3.72
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 3.72
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.68
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.68
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.67
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.65
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 3.64
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 3.64
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.63
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 3.63
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 3.6
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 3.6
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.6
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.59
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.59
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.58
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 3.57
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 3.55
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.55
Identification of HOXB13 target genes responsive to BET inhibitors 3.52
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 3.44
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.44
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.44
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.43
Silencing SPIB in attached and floating state of H1703 lung cancer cells 3.43
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.43
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.39
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.37
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.34
RNA-seq analysis of differentiating human erythroblasts 3.34
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 3.3
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 3.3
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 3.27
HNRNPM-regulated splicing dependencies in prostate cancer 3.25
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.25
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 3.23
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 3.21
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.19
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.18
Biological effect of chronic mistranslation in mammalian cells 3.17
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 3.17
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 3.16
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.13
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 3.09
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 3.09
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.08
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 3.04
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.02
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.0
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 3.0
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 3.0
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.96
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.95
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.94
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.93
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.88
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.84
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 2.84
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 2.82
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.82
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 2.81
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 2.81
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.81
Capturing the Interactome of Newly Transcribed RNA 2.78
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.78
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 2.75
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.74
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.74
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.68
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.68
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.61
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.58
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 2.58
RNA-seq of RKO cells with cTAZ KO or putback 2.54
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 2.52
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 2.52
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.51
U2AF1 mutations alter splice site recognition in hematological malignancies 2.51
RNA polymerase in pre-B-ALL cell lines 2.43
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.41
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.33
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 2.33
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.3
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.3
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.28
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.28
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.28
Functional significance of the HIV-1 Tat signature amino acid residues 2.28
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.25
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.25
Co-regulation of splicing by Rbfox1 and hnRNP M 2.25
Lysine benzoylation is a novel histone mark 2.22
Lysine benzoylation is a novel histone mark [RNA-seq] 2.22
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.14
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.13
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.12
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.07
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.07
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.06
SRSF1 role in cellular gene expression and splicing 2.04
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.0
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 1.97
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 1.97
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.95
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.95
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.95
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.91
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.9
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.87
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.8
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.8
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.8
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.77
Targeted enhancer activation by a subunit of the integrator complex 1.77
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.72
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.72
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.69
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 1.68
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.67
Polarized B -cell functions 1.66
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.64
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.64
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.62
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.61
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.59
Exploring ILF2 regulatory genes by next-generation sequencing 1.59
Global transcriptome analysis of WT versus HEB-/- hESCs 1.58
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.56
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.56
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.55
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  1.52
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.52
RNAseq of T-ALL upon long non coding rna purturbation 1.51
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.46
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 1.45
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.45
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.44
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.42
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.42
H1609088 Human RNA-Sequencing 1.41
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 1.4
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.39
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.34
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 1.33
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.33
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.32
Myc activation coordinates gene transcription and protein translation responses 1.24
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.23
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.15
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.15
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.14
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.14
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.12
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.11
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.1
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 1.06
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 1.06
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.03
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.98
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.92
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.92
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.89
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.88
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.87
Gene expression changes due to PARP knockdown in human cells 0.83
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.76
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.73
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.73
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.69
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.69
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.55
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.54
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.51
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.5
MARS Seq data from human cortical organoids 0.49
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.47
Gene expression analysis upon mtDNA depletion 0.44
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.44
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.42
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.41
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.37
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.37
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.34
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.32
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.3
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 0.3
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.3
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.27
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 0.26
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.22
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.22
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.21
The MEF2B Regulatory Network 0.19
The MEF2B Regulatory Network - RNA-seq data 0.19
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.15
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.15
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.12
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.1
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.08
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.08
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.06
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.06
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.03
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.03
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.02
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.02
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation